Greater Cannabis Company, Inc.
GCANOTCHealthcare · Pharmaceutical Preparations · FL · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $12,630 | $48,044 |
| Operating income | −$183,005 | −$156,276 | −$175,364 | −$177,035 | −$343,146 | −$294,457 |
| Net income | −$331,612 | −$179,041 | −$188,402 | −$360,268 | −$602,226 | −$1.2M |
| Total assets | $815 | $57,785 | $172,276 | $280,447 | $392,937 | $180,120 |
| Total liabilities | $742,464 | $898,058 | $833,508 | $825,277 | $861,999 | $459,908 |
| Equity | −$741,649 | −$840,273 | −$661,232 | −$544,830 | −$469,062 | −$279,788 |
| EPS (diluted) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Shares out. | 930.9M | 804.6M | 732.6M | 508.6M | 478.6M | 60.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- 44.7%
- Return on assets
- −40688.6%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 91099.9%
- Debt / equity
- —
- Book value / share
- $-0.00
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -27447.42distress
- Accruals / assets
- −33307.9%clean
- Piotroski F-Score
- 1/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 2 warning● 2 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Apr 3, 2023
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2022
- NT 10-Qmissed a reporting deadline ↗Aug 17, 2021
- NT 10-Qmissed a reporting deadline ↗Nov 16, 2020
- NT 10-Qmissed a reporting deadline ↗Aug 13, 2020
- NT 10-Qmissed a reporting deadline ↗May 15, 2020
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Sapir Llc10% owner | Apr 4, 2025 | Grant | 100.0M | $0.00 |
| Anderson Jimmy Wayne10% owner | Dec 2, 2019 | Sell | 176,878 | $0.03 |
| Anderson Jimmy Wayne10% owner | Nov 27, 2019 | Sell | 195,080 | $0.05 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 231 | 1.0 | -95.2% |
| Apr 30, 2026 | 4,837 | 1.0 | 0.0% |
| Apr 15, 2026 | 4,837 | 23.1 | -0.5% |
| Mar 31, 2026 | 4,863 | 1.0 | -34.3% |
| Mar 13, 2026 | 7,404 | 1.0 | +100.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Amended charter or bylaws · Other material eventOct 27, 2025
- Amended charter or bylaws · Other material eventOct 15, 2025
- Unregistered equity sale · Director / officer changeApr 10, 2025
- Changed auditorMar 6, 2025
- Amended charter or bylawsAug 16, 2023
- Changed auditorJan 26, 2023
- Entered a material agreementJun 21, 2022
- Entered a material agreementMay 19, 2022
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.